1. Schwarz L, Cauchy F, Conti F et al (2014) Preliminary report of major surgery in liver transplant recipients receiving m-TOR inhibitors without therapeutic discontinuation. World J Surg. doi: 10.1007/s00268-014-2693-x
2. Nashan B, Citterio F (2012) Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature. Transplantation 94(6):547–561
3. Klintmalm GB, Nashan B (2014) The role of mTOR inhibitors in liver transplantation: reviewing the evidence. J Transplant 2014:845438
4. ZORTRESS (prescribing information) (2012) Novartis Pharmaceuticals, Corp, East Hanover
5. European Medicines Agency (2011) Rapamune EPAR summary for the public. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000273/WC500046438.pdf . Accessed 28 June 2014